Tecvayli-Darzalex Faspro combo extends survival in myeloma trial
People with hard-to-treat myeloma given a combination of Tecvayli (teclistamab) and Darzalex Faspro (daratumumab and hyaluronidase-fihj) — both approved cancer therapies from…
Myeloma
When self-care feels like another thing on the to-do list
My therapist advised me to engage in more meditation. A friend sent me a link to a YouTube channel dedicated to yoga. In the waiting…
Results expected soon on burixafor for myeloma stem cell transplants
Results from a clinical trial testing Exicure‘s therapy candidate burixafor (GPC-100) in stem cell transplants for people with myeloma are expected soon — and the developer…
Feeling relieved, then guilty, when my mum falls asleep
The most peaceful part of my day starts around 10:36 p.m. That’s when my mother has taken her last pills, I’ve checked her vitals, and…
Developers partner on cemsidomide plus Elrexfio to treat myeloma
C4 Therapeutics and Pfizer are teaming up to evaluate whether combining C4’s investigational oral therapy cemsidomide with Pfizer’s approved multiple myeloma treatment Elrexfio…
The things I miss about life before caregiving
I miss deliberately and intentionally placing my phone on silent mode. I miss the luxury of my phone battery dying, of my being out of…
Iberdomide helps eliminate myeloma cells, trial data show
Iberdomide can help eliminate cancer cells in people with relapsed or refractory multiple myeloma, according to clinical trial results announced by Bristol Myers Squibb…
The hidden signs of myeloma that whisper before they shout
When people think of cancer, they often imagine clear warning signs, such as a lump, dramatic weight loss, or a test result that leaves no…
Planning for the future when even tomorrow feels fragile
A few weeks ago, my cousin asked if I would join her family for her oldest son’s wedding ceremony this November in Dubai. “We’ve started…
Myeloma treatment combo sees 100% response rate in trial
Combination treatment with Tecvayli (teclistamab-cqyv) and Darzalex Faspro (daratumumab and hyaluronidase-fihj) led to a 100% response rate for 49 people with newly diagnosed…
